Physician profile
Jorge Luengas
NPI 1407878879
$1,893.57
in general payments reported to CMS, 2019-2025
16 companies · $634 in 2025
The $634 reported for 2025 was more than what 78% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $27.48 · 2021: $190 · 2022: $140 · 2023: $476 · 2024: $425 · 2025: $634.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,536.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,535.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $793.95 | 2023-2025 | Ozempic, Wegovy, Rybelsus |
| Lilly USA, LLC | $324.31 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Abbott Laboratories | $226.65 | 2021-2025 | Freestyle Libre 3 |
| Exact Sciences Corporation | $117.80 | 2023-2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $75.71 | 2023-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Pfizer INC. | $65.29 | 2024-2025 | |
| Sanofi Pasteur INC. | $47.17 | 2025 | |
| Myriad Women'S Health, INC. | $47.00 | 2023 | Myrisk |
| Sanofi-Aventis U.S. LLC | $43.36 | 2022 | |
| Dexcom, INC. | $27.70 | 2023 | Dexcom G6 Transmitter |
| Biosense Webster, INC. | $27.48 | 2020 | |
| Dynavax Technologies Corporation | $25.92 | 2023 | Heplisav-B |
| Corcept Therapeutics | $21.77 | 2022 | |
| Merck Sharp & Dohme LLC | $17.59 | 2025 | Capvaxive, Gardasil 9 |
| Amneal Pharmaceuticals LLC | $16.04 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $15.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jorge Luengas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.